Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Post-Op Pain in Colon Surgery
NCT02052557Phase 4Completed
- Sponsor
- Des Moines University
- Start
- Feb 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine extended release liposome injection in postoperative pain (2 arms), sponsored by Des Moines University. Primary endpoint: Patient Controlled Analgesia Usage at 48 hours. Started Feb 2013; status: completed.
02
Drugs
bupivacaine extended release liposome injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02052557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052557.